Mission Kymera’s mission is to discover, develop and commercialize novel and transformative therapies that intend to improve the lives of patients with serious diseases. We are looking for creative, dynamic, and forward-thinking innovators to join our expert team of employees dedicated to realizing the potential of protein degraders and achieve the broadest possible impact for patients.
Description Kymera Therapeutics is a clinical stage biopharmaceutical company pioneering a transformative new modality, “targeted protein degradation” (TPD), with the ability to pursue targets long considered undruggable and to treat disease in entirely new ways. Its mission is to discover, develop and commercialize novel and transformative therapies to improve the lives of patients with serious diseases. Our team has developed a proprietary drug discovery engine, Pegasus, to enable the design of highly selective, small molecule protein degraders with potent activity against a broad range of disease indications. We are committed to selecting targets with the broadest possible impact across multiple disease indications with high unmet medical need to realize the full potential of TPD.
Kymera is led by an expert team of dedicated scientists and drug hunters, with decades of experience in the foundational areas of targeted protein degradation and drug development.
Kymera Therapeutics has an employee rating of 3.9 out of 5 stars, based on 16 company reviews on Glassdoor which indicates that most employees have a good working experience there. The Kymera Therapeutics employee rating is in line with the average (within 1 standard deviation) for employers within the Pharmaceutical & Biotechnology industry (3.5 stars).
Overall, 70% of employees would recommend working at Kymera Therapeutics to a friend. This is based on 16 anonymously submitted reviews on Glassdoor.
57% of job seekers rate their interview experience at Kymera Therapeutics as positive. Candidates give an average difficulty score of 3 out of 5 (where 5 is the highest level of difficulty) for their job interview at Kymera Therapeutics.